Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Cancers|March 23, 2018
Erratum: Roche, J. The Epithelial-to-Mesenchymal Transition in Cancer. Cancers, 2018, 10, 52Joëlle RocheScience'S STKE : Signal Transduction Knowledge Environment|May 26, 2005
Class 3 semaphorin signaling: the end of a dogmaVincent Potiron, Joëlle RocheEuropean Journal of Medicinal Chemistry|June 19, 2016
Inside HDACs with more selective HDAC inhibitorsJoëlle Roche, Philippe BertrandAdvances in Experimental Medicine and Biology|March 5, 2003
Neuropilin and its ligands in normal lung and cancerJoëlle Roche, Harry Drabkin, Elisabeth BrambillaLeukemia & Lymphoma|September 17, 2004
p14ARF, p15INK4b and p16INK4a methylation status in chronic myelogenous leukemiaSophie Kusy, Christian-Jacques Larsen, Joëlle RocheCancer Letters|July 16, 2008
Semaphorins and their receptors in lung cancerVincent A Potiron, Joëlle Roche, Harry A DrabkinCancers|July 5, 2017
Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung CancerJoëlle Roche, Robert M Gemmill, Harry A DrabkinCell Adhesion & Migration|February 9, 2010
Guidance molecules in lung cancerPatrick Nasarre, Vincent Potiron, Harry Drabkin, et al.Bioorganic & Medicinal Chemistry Letters|September 28, 2007
Antiproliferative activities of a library of hybrids between indanones and HDAC inhibitor SAHA and MS-275 analoguesCédric Charrier, Joëlle Roche, Jean-Pierre Gesson, et al.Pageof 4